SOC 29-1051.00

Pharmacist

VerdictHigher Risk
Signal 01 · structural exposure
70
/ 100

Structural exposure score derived from 2 independent sources (OpenAI "GPTs are GPTs" (human_rating_beta) + AIOE (Felten, Raj & Seamans)), each normalized against its own full reference population and combined by simple average, then converted to a percentile.

Signal 02 · real-world AI usage
Not yet available

We have not ingested real-world usage data for this occupation yet. We show a band only where genuine data exists, rather than estimate one.

What this is not
Neither reading measures whether any single pharmacist has lost work to AI. That data does not exist anywhere yet — both signals describe tasks, not headcount.
How we calculated this →

What a pharmacist actually does

Pharmacists are the last licensed check on every prescription before a patient takes it. Their core legal duty is verification: confirming a prescribed drug, dose, and combination are safe for a specific patient, catching dangerous interactions, allergy conflicts, or prescribing errors before medication reaches anyone. This clinical judgment call, not the physical act of counting pills, is what the license is built around, and it is the part of the job that has proven hardest to automate away.

Beyond verification, pharmacists counsel patients directly on how to take a medication safely, what side effects to expect, and how a new prescription interacts with what a patient already takes. Many now provide direct clinical services once reserved for physicians: administering vaccinations, running smoking-cessation and diabetes-management programs, monitoring blood pressure and glucose, and adjusting therapy in collaboration with prescribers.

Compounding pharmacists still calculate, weigh, and mix custom medications and sterile IV solutions by hand for patients whose needs don't fit a standard manufactured dose. Hospital pharmacists work as part of a clinical care team, reviewing every inpatient's drug regimen for safety and effectiveness.

Specialty and community pharmacies add further variation: a specialty pharmacist manages complex, high-cost biologic and oncology medications requiring prior-authorization coordination with insurers, while an independent community pharmacist often builds long-term relationships with patients managing multiple chronic conditions across years of refills. Long-term-care pharmacists review medication regimens for nursing-home residents, a population especially vulnerable to dangerous drug interactions given the number of prescriptions many are on simultaneously.

Nuclear pharmacists, a small specialty, prepare and dispense radioactive materials used in diagnostic imaging under an additional layer of federal regulatory oversight.

Most pharmacists work in retail pharmacies, hospitals, or clinics, all of them Doctor of Pharmacy (Pharm. D. ) holders who completed a 4-year professional degree after prerequisite science coursework, then passed a licensing exam. Every US state requires this license to practice, and a pharmacist's malpractice liability attaches personally to the individual who verified a given prescription.

The retail dispensing side of the job has changed substantially in the last few years as large chains have shifted routine pill-counting and packaging to centralized robotic fill centers, while hospital and clinical pharmacist roles have expanded in the opposite direction, taking on more direct patient care, immunizations, and chronic-disease management once handled almost exclusively by physicians.

Why it reads this way

Pharmacist's structural score (30/100) is well inside this site's high-exposure range, and the disconfirming evidence here is real, not hypothetical, so this verdict is disclosed with a genuine caveat rather than a clean "safe" story. Central-fill robotic dispensing is a real, named, commercial-scale, growing deployment: CVS runs centralized AI/robotics serving 9,000+ stores, Walgreens' robotic hubs now fill roughly 60% of prescriptions across about 3,000 stores, and Walmart's automated facilities process up to 100,000 prescriptions daily.

This has coincided with a real, documented decline in retail pharmacist headcount, roughly 8,200 retail positions lost in 2025 alone, on top of about 11,700 lost across 2023 to 2024 combined, per pharmacy-industry analyst tracking. That is genuine category-1 evidence against an unqualified "safe" reading, and it is weighed here rather than discarded.

What keeps the occupation out of "At risk" is a real legal wall with actual enforcement teeth, not a nominal one: every US state requires a pharmacist license to practice, and the specific pharmacist who verifies a prescription carries personal liability for that verification.

Even where states permit "tech-check-tech" programs letting trained technicians handle routine refill verification, that authority exists only under the direct supervision of, and legal responsibility of, a licensed pharmacist physically present in the dispensing area; the license is not handed to the software or the technician. Controlled substances still require pharmacist-only verification in most states.

Critically, this isn't just a legal technicality sitting on top of a shrinking occupation, BLS actually projects 5% net employment growth for pharmacists from 2025 to 2035 with roughly 12,500 annual openings, and industry reporting describes hospitals and health systems shifting from decades of oversupply to a genuine pharmacist shortage.

The retail decline and the clinical-role growth are two sides of the same automation story: robots absorbed the mechanical counting-and-labeling task, and pharmacists were redeployed toward the verification, counseling, and clinical-service work robots cannot legally or practically perform, not toward the unemployment line.

This is a case where the numeric score and the real-world evidence genuinely point in different directions rather than confirming each other, exactly the kind of discrepancy this site's research protocol requires investigating rather than silently resolving.

A low structural score built around language/cognitive task exposure correctly flags that much of a pharmacist's documentation and counseling work resembles what AI systems are good at; what it cannot see is that the specific legal act of verification, not the underlying analysis, is what the license actually protects, and that act still requires a named, individually liable human by law in all 50 states.

Skills this role draws on

We don't yet have task-by-task time-share data for this occupation, so we can't show which specific tasks carry the exposure score above. This is the real skill set instead.

Prescription Verification & Drug Interaction ScreeningPatient Counseling & Medication Safety EducationSterile Compounding & Pharmaceutical CalculationsClinical Drug Therapy Monitoring & Collaboration with PrescribersImmunization Administration & Chronic Disease Management ServicesRegulatory Compliance & Controlled Substance Recordkeeping
Pay & demand

Typical salary range (USD)

$99,290–$174,230

Average: $140,910/yr

Demand
High
Growth outlook
Strong
Projected growth
5% (2025-2035, faster than the 3% all-occupation average, per BLS Occupational Outlook Handbook; ~12,500 annual openings, concentrated in hospital/clinical settings)

Range source: BLS Occupational Outlook Handbook, 2025
Average source: BLS Occupational Outlook Handbook, May 2025 median annual wage for Pharmacists (29-1051.00)

Training
6+ years (2+ years prerequisite coursework + 4-year Doctor of Pharmacy degree), plus licensing exam
Doctor of Pharmacy (Pharm.D.) Degree (ACPE-accredited)NAPLEX Licensing ExaminationState Pharmacist License (required in all 50 states)
Research verdict
Assessed as of 2026-09-08
AI-resistant despite the paperwork

Pharmacist scores 30/100, deep in this site's high-exposure range, and real disconfirming evidence was found and weighed: commercial-scale central-fill robotics (CVS, Walgreens, Walmart) has coincided with a documented ~8,200 retail pharmacist job loss in 2025 alone. What prevents an "At risk" verdict is a legal wall with real enforcement teeth (every state requires a license, and verification liability attaches personally to the pharmacist, not the software or a supervised technician) combined with net occupational growth, BLS projects 5% growth through 2035 with hospitals facing a genuine pharmacist shortage, showing automation displaced the mechanical dispensing task while pharmacists were redeployed to verification, counseling, and clinical services robots cannot perform. Medium confidence reflects this genuinely mixed evidence picture rather than a clean read in either direction.

Last updated: December 2025Source: BLS Occupational Outlook Handbook, 2025

Data sources & methodology

Salary data: BLS Occupational Outlook Handbook, 2025. Min/max figures represent the 10th–90th percentile annual wage range across the United States. Average figure sourced separately: BLS Occupational Outlook Handbook, May 2025 median annual wage for Pharmacists (29-1051.00).

Automation Risk Score: Based on O*NET occupational analysis (29-1051.00) evaluating task complexity, physical requirements, social intelligence, and environmental variability. Methodology based on research from Frey & Osborne (Oxford, 2017).

Growth projections: 5% (2025-2035, faster than the 3% all-occupation average, per BLS Occupational Outlook Handbook; ~12,500 annual openings, concentrated in hospital/clinical settings), based on BLS Occupational Outlook Handbook.

Learn more about our methodology